RayzeBio, Inc (NASDAQ:RYZB) IPO will take place September, 15 on the NASDAQ exchange under the ticker RYZB.
The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 13, 2024.
See also: Benzinga IPO Calendar
About RayzeBio, Inc
RayzeBio, Inc is a building a vertically integrated radiopharmaceutical therapeutics company with our lead program in a Phase 3 clinical trial. We believe we have established a leadership position in the emerging radiopharmaceutical therapeutics modality.
See also: Benzinga’s Most Shorted Stocks
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
